The Valley Desk

ArticleAlimentary pharmacology & therapeuticsPublished

Oral vancomycin is associated with improved inflammatory bowel disease clinical outcomes in primary sclerosing cholangitis-associated inflammatory bowel disease (PSC-IBD): A matched analysis from the Paediatric PSC Consortium

12 of 39 authors shown in byline order.

Read the publication ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Children’s Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Alimentary pharmacology & therapeutics
Published
Subject terms
Humans; Cholangitis, Sclerosing; Inflammatory Bowel Diseases; Vancomycin; Anti-Bacterial Agents; Treatment Outcome; Remission Induction; Administration, Oral; Severity of Illness Index; Retrospective Studies; Cohort Studies; Adolescent
PubMed ID
38462727
Added to directory
Source checked

Report a correction or request removal